臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

关于TAIR
	计画说明

浏览
	典藏机构
	作者
	题名
	日期
	统计图表
	机构即时统计
	学术趋势

消息
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

著作权
	出版社及期刊政策查询
	TAIR著作权会议记录

相关连结
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

跳至:
或输入年份:

从最近的开始

由旧到新排序

显示项目 2288276-2288300 / 2346269 (共93851页)
<< < 91527 91528 91529 91530 91531 91532 91533 91534 91535 91536 > >>
每页显示[10|25|50]项目

机构	日期	题名	作者
臺大學術典藏	2022-08-19T00:21:04Z	Bortezomib suppresses focal adhesion kinase expression via interrupting nuclear factor-kappa B	Liou J.-Y.; Shyue S.-K.; Chang C.-C.; Golubovskaya V.M.; Shen T.-L.; Shen Y.-C.; CHIUN HSU; Kuo C.-C.; Ko B.-S.; Chang T.-C.; Chen C.-H.; Liu C.-C.
臺大學術典藏	2022-08-19T00:21:04Z	Geographic difference in survival outcome for advanced hepatocellular carcinoma: Implications on future clinical trial design	CHIUN HSU; Shen Y.-C.; Cheng C.-C.; Hu F.-C.; Cheng A.-L.
臺大學術典藏	2022-08-19T00:21:04Z	Overexpressed focal adhesion kinase predicts a higher incidence of extrahepatic metastasis and worse survival in hepatocellular carcinoma	Jan Y.-J.; Ko B.-S.; CHIUN HSU; Chang T.-C.; Chen S.-C.; Wang J.; Liou J.-Y.
臺大學術典藏	2022-08-19T00:21:04Z	Sorafenib for the treatment of hepatocellular carcinoma across geographic regions	CHIUN HSU; Shen Y.-C.; Cheng A.L.
臺大學術典藏	2022-08-19T00:21:05Z	Bortezomib overcomes tumor necrosis factor-related apoptosis-inducing ligand resistance in hepatocellular carcinoma cells in part through the inhibition of the phosphatidylinositol 3-kinase/Akt pathway	Chen K.-F.; Yeh P.-Y.; CHIUN HSU; Hsu C.-H.; Lu Y.-S.; Hsieh H.-P.; Chen P.-J.; Cheng A.-L.
臺大學術典藏	2022-08-19T00:21:05Z	Induction of Bim expression contributes to the antitumor synergy between sorafenib and mitogen-activated protein kinase/extracellular signal-regulated kinase kinase inhibitor CI-1040 in hepatocellular carcinoma	Cheng A.-L.; CHIUN HSU; Wang D.-S.; Lu Y.-S.; Fan H.-H.; Ou D.-L.; Shen Y.-C.; Liang J.-D.; Liou J.-Y.; Yu S.-L.
臺大學術典藏	2022-08-19T00:21:06Z	Nuclear overexpression of mitotic regulatory proteins in biliary tract cancer: Correlation with clinicopathologic features and patient survival	Shen Y.-C.; Hu F.-C.; Jeng Y.-M.; Chang Y.-T.; Lin Z.-Z.; Chang M.-C.; CHIUN HSU; Cheng A.-L.
臺大學術典藏	2022-08-19T00:21:07Z	Gemcitabine plus conventional-dose epirubicin versus gemcitabine plus cisplatin as first-line chemotherapy for stage IIIB/IV non-small cell lung carcinoma-A randomized phase II trial	CHIUN HSU; Kuo S.-H.; Hu F.-C.; Cheng A.-L.; Shih J.-Y.; Yu C.-J.; Lin C.-C.; Huang T.-C.; Yang P.-C.; Yang C.-H.
臺大學術典藏	2022-08-19T00:21:07Z	Serum vascular endothelial growth factor/soluble vascular endothelial growth factor receptor 1 ratio is an independent prognostic marker in pancreatic cancer	Chang Y.-T.; Chang M.-C.; Wei S.-C.; Tien Y.-W.; CHIUN HSU; Liang P.-C.; Tsao P.-N.; Jan I.-S.; Wong J.-M.
臺大學術典藏	2022-08-19T00:21:07Z	Weekly cisplatin, infusional high-dose 5-fluorouracil and leucovorin for advanced, recurrent and metastatic cervical carcinoma	Hsiao S.-M.; Chen C.-A.; CHIUN HSU; Lin H.-H.; Hsieh C.-Y.; Wei L.-H.
臺大學術典藏	2022-08-19T00:21:08Z	Predictors of toxicity of weekly docetaxel in chemotherapy-treated non-small cell lung cancers	Chen J.-P.; Lo Y.; Yu C.-J.; CHIUN HSU; Shih J.-Y.; Yang C.-H.
臺大學術典藏	2022-08-19T00:21:08Z	A revisit of prophylactic lamivudine for chemotherapy-associated hepatitis B reactivation in non-Hodgkin's lymphoma: A randomized trial	Cheng A.-L.; Chen P.-J.; Wu H.-B.; Tien H.-F.; Chao T.-Y.; Liu T.-W.; Li C.-C.; Liao Y.-M.; Chang M.-C.; Young J.-H.; Hsiao H.-H.; Lin T.-H.; Lin S.-F.; Wang M.-C.; Hwang W.-S.; Su I.-J.; CHIUN HSU; Hsiung C.A.
臺大學術典藏	2022-08-19T00:21:08Z	Outcome of advanced nonsmall cell lung cancer patients receiving gemcitabine and weekly paclitaxel as first-line treatment	Lin Z.-Z.; CHIUN HSU; Chang Y.-C.; Yu C.-J.; Hsu C.-H.; Lin C.-C.; Cheng A.-L.; Yang P.-C.; Yang C.-H.
臺大學術典藏	2022-08-19T00:21:09Z	Comparison of hypoplastic myelodysplastic syndrome (MDS) with normo-/hypercellular MDS by International Prognostic Scoring System, cytogenetic and genetic studies	Huang T.-C.; Ko B.-S.; Tang J.-L.; CHIUN HSU; Chen C.-Y.; Tsay W.; Huang S.-Y.; Yao M.; Chen Y.-C.; Shen M.-C.; Wang C.-H.; Tien H.-F.
臺大學術典藏	2022-08-19T00:21:09Z	Dynamic MRI signals in the second week of radiotherapy relate to treatment outcomes of hepatocellular carcinoma: A preliminary result	Liang P.-C.; Ch'ang H.-J.; CHIUN HSU; Tseng S.S.; Shih T.T.F.; Wu Liu T.
臺大學術典藏	2022-08-19T00:21:09Z	Multifractionated paclitaxel and cisplatin combined with 5-fluorouracil and leucovorin in patients with metastatic or recurrent esophageal squamous cell carcinoma	Lin C.-C.; Yeh K.-H.; Yang C.-H.; CHIUN HSU; Tsai Y.-C.; Hsu W.-L.; Cheng A.-L.; Hsu C.-H.
臺大學術典藏	2022-08-19T00:21:10Z	A phase II trial of weekly paclitaxel and high-dose 5-fluorouracil plus leucovorin in patients with chemotherapy-pretreated metastatic breast cancer	Lin C.-C.; Cheng A.-L.; Hsu C.-H.; Lu Y.-S.; CHIUN HSU; Yeh K.-H.; Wu C.-Y.; Huang C.-S.; Yang C.-H.
臺大學術典藏	2022-08-19T00:21:10Z	Survival outcome and predictors of gefitinib antitumor activity in East Asian chemonaive patients with advanced nonsmall cell lung cancer	Yang P.-C.; Chang G.-C.; CHIUN HSU; Gow C.-H.; Yang C.-H.; Shih J.-Y.; Chen K.-C.; Yu C.-J.; Yang T.-Y.; Lin C.-P.; Su W.-P.
臺大學術典藏	2022-08-19T00:21:10Z	Expression of the caudal-type homeodomain transcription factor CDX2 is related to clinical outcome in biliary tract carcinoma	Chang Y.-T.; CHIUN HSU; Jeng Y.-M.; Chang M.-C.; Wei S.-C.; Wong J.-M.
臺大學術典藏	2022-08-19T00:21:11Z	CD24 expression is a prognostic factor in intrahepatic cholangiocarcinoma	Su M.-C.; CHIUN HSU; Kao H.-L.; Jeng Y.-M.
臺大學術典藏	2022-08-19T00:21:12Z	Phase I-II trial of weekly gemcitabine plus high-dose 5-fluorouracil and leucovorin in advanced pancreatic cancer	Shiah H.-S.; Cheng A.-L.; CHIUN HSU; Hsu C.-H.; Liu T.-W.; Chang J.-Y.; Jan C.-M.; Chao Y.; Yu W.-L.; Chuang T.-R.; Whang-Peng J.; Chen L.-T.
臺大學術典藏	2022-08-19T00:21:12Z	Phase I study of biweekly gemcitabine followed by oxaliplatin and simplified 48-h infusion of fluorouracil/leucovorin for advanced pancreatic cancer	Ch'ang H.-J.; Wang C.-C.; Cheng A.-L.; CHIUN HSU; Lu Y.-S.; Chang M.-C.; Lin J.-T.; Wang H.-P.; Shiah H.-S.; Liu T.-W.; Chang J.-Y.; Whang-Peng J.; Chen L.-T.
臺大學術典藏	2022-08-19T00:21:13Z	Unexpected rapid progression of metastatic adenoid cystic carcinoma during treatment with imatinib mesylate	Lin C.-H.; Yen R.-F.; Jeng Y.-M.; Tzen C.-Y.; CHIUN HSU; Hong R.-L.
臺大學術典藏	2022-08-19T00:21:13Z	Gefitinib treatment for non-small cell lung cancer - A study including patients with poor performance status	Shih J.-Y.; CHIUN HSU; Yang P.-C.; Su W.-P.; Yang C.-H.; Yu C.-J.
臺大學術典藏	2022-08-19T00:21:14Z	Significant difference in the trends of female breast cancer incidence between Taiwanese and Caucasian Americans: Implications from age-period-cohort analysis	Shen Y.-C.; Chang C.-J.; CHIUN HSU; Cheng C.-C.; Chiu C.-F.; Cheng A.-L.

显示项目 2288276-2288300 / 2346269 (共93851页)
<< < 91527 91528 91529 91530 91531 91532 91533 91534 91535 91536 > >>
每页显示[10|25|50]项目

	English \| 正體中文 \| 简体中文 \| 总笔数 :2853327
	造访人次 : 45088748 在线人数 : 1078 教育部委托研究计画计画执行:国立台湾大学图书馆